Topotecan in Treating Children With Refractory Leukemia

Completed · Phase 1

Conditions studied: Leukemia

In brief

Phase I trial to study the effectiveness of topotecan in treating children with refractory leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.

Key facts

Study ID
NCT00002705
Run by
National Cancer Institute (NCI)
People needed
3
Starts
1996-04-01
Last updated by the study team
2013-02-01

Who can join

Age: any, up to 20. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.